King Pharmaceuticals KG European Hospital Liability — Year 2
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo.
The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's european hospital liability — year 2.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's european hospital liability — year 2?
- King Pharmaceuticals (KG) reported european hospital liability — year 2 of 7.1% in Q4 2025.
- What does european hospital liability — year 2 mean?
- This metric tracks the financial performance or claim development for the second year of the underwriting cycle within the European Hospital Liability segment. It allows for the assessment of how loss estimates mature and change as more information becomes available after the initial policy year.